We previously suggested that APOBEC activity on BIR intermediates could be a potent source of kataegis in human cancer, which are simultaneously formed localized mutation events (i.e. mutation clusters) frequently associated with complex chromosomal rearrangements. The gene discussed is KCNJ11; the disease is cancer.